News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER Research Update: September 2026
RECOVER researchers continue to publish findings that could help scientists, doctors, patients, and caregivers navigate the complexities of Long COVID.
Research Update
15 Results
15 Results
RECOVER launches new funding opportunity for pathobiology research
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
Announcement
RECOVER-TLC to host next webinar July 16, 2026
NIH and FNIH leaders will provide an overview of the clinical trial process and updates on the status of RECOVER-TLC.
Announcement
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
RECOVER-AUTONOMIC clinical trial results shared at 2026 ACC Conference
The RECOVER-AUTONOMIC (Ivabradine) clinical trial tested whether ivabradine, an oral medication used to lower heart rate, could be used to manage a Long COVID symptom called postural orthostatic tachycardia syndrome (POTS).
Announcement
RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will share insights and answer questions about the progress being made on the first wave of RECOVER-TLC clinical trials.
Announcement
RECOVER-TLC opens expanded enrollment in REVERSE-LC clinical trial
Researchers at 17 study sites across the US will test a possible treatment to help improve thinking and memory problems and reduce fatigue for people who have Long COVID.
Announcement
First results from RECOVER-AUTONOMIC clinical trials to be shared at upcoming conference
Results from the RECOVER-AUTONOMIC Moderate POTS (Ivabradine) clinical trial will be presented at an upcoming session of the American College of Cardiology (ACC) Annual Conference on March 28, 2026.
Announcement
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement